RS
EW icon

Rakuten Securities’s Edwards Lifesciences EW Stock Holding History

Rakuten Securities’s Portfolio EW Stock Details EW Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$181 Sell
2
-2
-50% -$168 ﹤0.01% 830
2026
Q1 		$320 Sell
4
-2
-33% -$165 ﹤0.01% 775
2025
Q4 		$512 Buy
6
+5
+500% +$410 ﹤0.01% 757
2025
Q3 		$78 Sell
1
-374
-100% -$29.2K ﹤0.01% 876
2025
Q2 		$29.3K Buy
375
+302
+414% +$22.5K 0.01% 277
2025
Q1 		$5.29K Sell
73
-179
-71% -$12.8K ﹤0.01% 491
2024
Q4 		$18.7K Buy
252
+244
+3,050% +$17.1K 0.01% 315
2024
Q3 		$528 Sell
8
-11
-58% -$799 ﹤0.01% 630
2024
Q2 		$1.75K Sell
19
-36
-65% -$3.19K ﹤0.01% 497
2024
Q1 		$5.26K Buy
55
+11
+25% +$924 ﹤0.01% 396
2023
Q4 		$3.35K Buy
+44
New +$3.06K ﹤0.01% 392

Other funds holding EW

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
DZ Bank
DZ Bank Frankfurt Am Main, Germany $130B AUM 46.38% 1-Year Est. Return
Ninety One (UK)
Ninety One (UK) London, United Kingdom $44.7B AUM 17.24% 1-Year Est. Return

Rakuten Securities's EW Position: Q2 2026 in Review

Rakuten Securities reduced its Edwards Lifesciences (EW) stake by 50% in Q2 2026, selling an estimated $168 and leaving 2 shares worth $181. The position accounts for ﹤0.01% of the portfolio, ranked #830.

Rakuten Securities first reported a position in EW in Q4 2023 and has held it in 11 quarters since. The position peaked at $29.3K in Q2 2025. 1,325 funds tracked by Wall St. Rank hold EW as of Q2 2026.

  • Rakuten Securities held 2 shares of Edwards Lifesciences worth $181 as of Q2 2026.
  • Rakuten Securities sold 2 Edwards Lifesciences shares in Q2 2026, an estimated $168.
  • Edwards Lifesciences made up ﹤0.01% of Rakuten Securities's portfolio in Q2 2026, its #830 holding.
  • Rakuten Securities first reported a position in Edwards Lifesciences in Q4 2023 and has held it in 11 quarters since.
  • Rakuten Securities's Edwards Lifesciences position peaked at $29.3K in Q2 2025.
  • 1,325 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q2 2026.

Based on Rakuten Securities's 13F filing for Q2 2026, filed 12 Aug 2026.